Study Evaluating LXR-623 in Healthy Japanese Adults

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: LXR-623

Study type: Interventional

Funder types: Industry

Identifiers

NCT00385489

3201A1-102

Details and patient eligibility

About

The purpose of this study is to evaluate the safety of LXR-623 in healthy Japanese subjects.

Sex: Male

Ages: 20 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy, Japanese Males aged 20-45 years

Exclusion criteria

• A history or active presence of clinically important medical disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind